The U.S. Court of Appeals for the D.C. Circuit has denied the American Hospital Association’s lawsuit against HHS for $1.6 billion in cuts made to the 340B drug pricing program beginning this year. The lawsuit had previously been denied because the cuts hadn’t yet taken effect.